
Lucid Diagnostics Inc (LUCD) rating initates by Ascendiant Capital Markets
Lucid Diagnostics Inc’s recently made public that its Director Matheis Dennis acquired Company’s shares for reported $0.1 million on Aug
Lucid Diagnostics Inc’s recently made public that its Director Matheis Dennis acquired Company’s shares for reported $0.1 million on Aug
Lucid Diagnostics Inc’s filing revealed that its Director Matheis Dennis acquired Company’s shares for reported $0.24 million on May 20
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Lucid Diagnostics Inc revealed its Director Matheis Dennis acquired Company’s shares for reported $0.24 million on May
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Lucid Diagnostics Inc’s recent filing unveils that its Director Matheis Dennis acquired Company’s shares for reported $0.24 million on May
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Lucid Diagnostics